Literature DB >> 10172065

Is alteplase (t-PA) more cost-effective than streptokinase?

L A Sanchez1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 10172065     DOI: 10.2165/00019053-199202050-00011

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  1 in total

1.  Potential cost effectiveness of intravenous tissue plasminogen activator versus streptokinase for acute myocardial infarction.

Authors:  V Goel; C D Naylor
Journal:  Can J Cardiol       Date:  1992 Jan-Feb       Impact factor: 5.223

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.